氯噻吨自1960年左右用于临床以来,已证实该药适用于精神分裂病、偏执性精神病、躁狂症和智能发育不全伴发兴奋躁动。其长效剂型为氯噻吨癸酸酯(α-clopenthixoldecanoate)临床报告始于1973年,特别对于需要镇静的精神分裂症患者,是长期治疗的一种理想的长效神经阻断剂;国内尚无报告。本药为α—氯噻吨经癸酸酯化的20％油溶剂,药理研究和临床观察都报告其作用时间为2周,200mg(1ml)的临床效应相当于长效氟奋乃静25mg或长效三氟噻吨20mg。用作肌肉 Chlorothioxanthine has been used clinically since around 1960 and has proven its efficacy in the treatment of schizophrenia, paranoid psychosis, mania and mental retardation. The long-acting dosage form is chlorothioxanthone (α-clopenthixoldecanoate) clinical report began in 1973, especially for those patients with sedated schizophrenia, long-term treatment is an ideal long-acting nerve blockers; domestic No report. The drug is α-chlorothioxanthone capric esterified 20% oil solvent, pharmacological studies and clinical observations have reported that its role for 2 weeks, 200mg (1ml) of the clinical effect equivalent to long-acting fluphenazine 25mg or Long-acting trifluoperazine 20mg. Used as muscle